On Monday, HSBC Holdings Plc (LON:HSBA) shares edged higher 1.52% after announcing its most recent quarterly results. The company reported its fiscal Q3 revenue and earnings before markets opened, posting a significant rise in pre-tax profit.
The company posted GAAP earnings per share of $0.18, representing year-over-year growth of about 157%. Its adjusted profit before tax (PBT) grew 36% to nearly $6 billion from the same period a year ago.
HSBC growth prospects
From a valuation perspective, HSBC shares trade at a trailing 12-month P/E ratio of 13.45, making the stock attractive to value investors.
In addition, the analysts expect HSCB’s earnings per share to grow by an annual rate of 67.90% over the next five years. As a result, long-term investors could find the stock as a compelling option for their portfolios.
Therefore, given the company’s recent profit growth, it could be time to bet on its exciting growth prospects.
Can the rally continue?
Technically, HSBC shares appear to be trading within an ascending channel formation in the intraday chart. As a result, the stock has surged several levels above the 100-day moving average, pushing it deep into overbought conditions.
Therefore, HSBC seems poised for an immediate pullback, with the profit-takers swooping in. However, given the current price levels against this year’s highs, the bull-run could continue.
Investors could target extended gains at about $34.02, or higher at $38.08, while $27.40 and $23.34 are crucial support zones.
Should profit-takers swoop in?
In summary, although it seems to be the perfect time to take some profits off HSBC shares, the bull run may not be over yet. The stock is yet to retest this year’s highs of about $32.38, despite surging deep into overbought conditions.
Therefore, given the company’s exciting earnings growth prospects and compelling valuation multiples, it may not be time to sell yet.
Where to buy right now
To invest simply and easily, users need a low-fee broker with a track record of reliability. The following brokers are highly rated, recognised worldwide, and safe to use: